Wednesday, February 21, 2018 from 12:00 PM to 2:00 PM MST
Add to Calendar 


Lory Student Center, North Ballroom

Colorado State University

Fort Collins, CO  

Driving Directions 


Steve Albers 
CSU Ventures 

This event is sponsored by: 


State of Innovation - CRISPR series 

Vic Myer, PhD

CTO, Editas Medicine

Prior to joining Editas, Dr. Myer served as Executive Director and Cambridge Site Head for the Developmental and Molecular Pathways (DMP) department at the Novartis Institutes for Biomedical Research Incorporated (NIBR). Previous to Novartis, Dr. Myer was a founding scientist and group leader at Akceli, Inc., a venture-backed systems-biology company focusing on commercialization of a high-throughput cell-based micro-array technology. Dr. Myer also served as senior scientist for Millennium Pharmaceuticals and held various roles at Corning, Inc.  Dr. Myer received his B.S. in biology (biochemistry) from Cornell University and his Ph.D. in molecular biophysics and biochemistry from Yale University. He was a postdoctoral research associate at the Whitehead Institute for Biomedical Research at Massachusetts Institute of Technology.


Please join us for the GRADUATE STUDENT LUNCHEON portion of the State of Innovation Speaker Series. 




Transitioning to Industry: 

What you should know about working in industry


Where: Lory Student Center, North Ballroom  

When: Wednesday, February 21st, 2018 

Time: 12:30-2:00 pm





The event is free and open to all Graduate Students and Post-Doctoral Fellows.

Lunch will be provided.  This professional development session will include discussion of acquiring the non-technical skills scientists need to become proficient and successful professionals.  


Registration is REQUIRED to receive lunch.



Co-hosted by CSUVentures and the Graduate School





About Editas Medicine:  Editas Medicine is a leading genome editing company and part of a transformational new area of health care – genomic medicine. The company was founded by pioneers and world leaders in genome editing bringing specific expertise in CRISPR/Cas9 and TALENs technologies. The company’s mission is to translate its proprietary technology into novel solutions to treat a broad range of genetically driven diseases.  http://www.editasmedicine.com/

About CSU Ventures: CSU Ventures is dedicated to the business of technology transfer and commercialization at Colorado State University. We bring innovations and technologies discovered at CSU into the marketplace for the benefit of society. Expertise in intellectual property, licensing, partnership-building, and entrepreneurship. We protect, manage and transfer CSU innovations by connecting individuals and companies with University researchers. CSU Ventures serves as a resource not only to CSU facutly and researchers, but also to industry, entreprenuers, and investors seeking to further research or commercialize a technology.  http://csuventures.org/

About the Graduate School: The Graduate School provides the leadership for graduate education, ensuring the highest program standards, and enhancing and strengthening the student experience by providing a range of innovative recruitment, retention, and professional development programs. Working closely with colleges, departments, programs, and offices across the campus, our mission is to provide an experience that supports excellence in graduate education and student success while assuring a culture of integrity and a commitment to diversity in all its forms.  Colorado State University is proud to be known as one of the nation’s leading public land-grant research universities, acknowledged for its teaching and learning excellence, national and international reputation for research and artistry, and public service at home and abroad.  http://graduateschool.colostate.edu/